CN110464720B - 一种具有防治肠易激综合征的蝉蜕乙酰多巴胺多聚体组合物及其应用 - Google Patents
一种具有防治肠易激综合征的蝉蜕乙酰多巴胺多聚体组合物及其应用 Download PDFInfo
- Publication number
- CN110464720B CN110464720B CN201910797530.6A CN201910797530A CN110464720B CN 110464720 B CN110464720 B CN 110464720B CN 201910797530 A CN201910797530 A CN 201910797530A CN 110464720 B CN110464720 B CN 110464720B
- Authority
- CN
- China
- Prior art keywords
- polymer composition
- bowel syndrome
- irritable bowel
- cicada slough
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000931705 Cicada Species 0.000 title claims abstract description 56
- -1 acetyl dopamine Chemical compound 0.000 title claims abstract description 56
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- VYFYYTLLBUKUHU-UHFFFAOYSA-N Dopamine Natural products NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 229960003638 dopamine Drugs 0.000 title claims abstract description 52
- 229920000642 polymer Polymers 0.000 title claims abstract description 45
- 208000002551 irritable bowel syndrome Diseases 0.000 title claims abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 230000000694 effects Effects 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000010828 elution Methods 0.000 claims abstract description 7
- 239000012153 distilled water Substances 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 239000011347 resin Substances 0.000 claims abstract description 6
- 229920005989 resin Polymers 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 4
- 239000013638 trimer Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 239000000539 dimer Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 abstract description 11
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 abstract description 11
- 230000009278 visceral effect Effects 0.000 abstract description 10
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 8
- 210000001072 colon Anatomy 0.000 abstract description 7
- 208000026935 allergic disease Diseases 0.000 abstract description 3
- 230000009610 hypersensitivity Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 48
- 210000001519 tissue Anatomy 0.000 description 10
- FSRLGULMGJGKGI-BTJKTKAUSA-N Trimebutine maleate Chemical group OC(=O)\C=C/C(O)=O.C=1C=CC=CC=1C(CC)(N(C)C)COC(=O)C1=CC(OC)=C(OC)C(OC)=C1 FSRLGULMGJGKGI-BTJKTKAUSA-N 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 210000000436 anus Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960005345 trimebutine Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001000583 Cryptotympana atrata Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010022680 Intestinal ischaemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 208000023505 abnormal feces Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 210000004953 colonic tissue Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | AWR/分 |
空白对照组 | 1.42±0.13** |
模型对照组 | 3.98±0.16 |
马来酸曲美布汀 | 1.79±0.59** |
蝉蜕乙酰多巴胺多聚体组合物低剂量组 | 3.24±0.65 |
蝉蜕乙酰多巴胺多聚体组合物中剂量组 | 1.46±0.26** |
蝉蜕乙酰多巴胺多聚体组合物高剂量组 | 1.32±0.17** |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910797530.6A CN110464720B (zh) | 2019-08-27 | 2019-08-27 | 一种具有防治肠易激综合征的蝉蜕乙酰多巴胺多聚体组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910797530.6A CN110464720B (zh) | 2019-08-27 | 2019-08-27 | 一种具有防治肠易激综合征的蝉蜕乙酰多巴胺多聚体组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110464720A CN110464720A (zh) | 2019-11-19 |
CN110464720B true CN110464720B (zh) | 2022-06-28 |
Family
ID=68513040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910797530.6A Active CN110464720B (zh) | 2019-08-27 | 2019-08-27 | 一种具有防治肠易激综合征的蝉蜕乙酰多巴胺多聚体组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110464720B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102285958A (zh) * | 2011-04-21 | 2011-12-21 | 李国玉 | 一组多巴胺多聚体和其衍生物及其制备方法和医药用途 |
-
2019
- 2019-08-27 CN CN201910797530.6A patent/CN110464720B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102285958A (zh) * | 2011-04-21 | 2011-12-21 | 李国玉 | 一组多巴胺多聚体和其衍生物及其制备方法和医药用途 |
Non-Patent Citations (3)
Title |
---|
Antioxidant and anti-inflammatory activities of N-acetyldopamine dimers from Periostracum Cicadae;Ming-Zhe Xu等;《Bioorganic & Medicinal Chemistry》;20060817;第14卷(第23期);7826-7834 * |
Two new N-acetyldopamine tetrapolymers from Periostracum Cicadae;Lu Yang等;《Journal of Asian Natural Products Research》;20120331;第14卷(第3期);204-209 * |
蝉蜕中乙酰多巴胺二聚体超高效液相色谱法多组分测定及其在药材中的分布;杨璐等;《沈阳药科大学学报》;20120131;第29卷(第1期);31-35 * |
Also Published As
Publication number | Publication date |
---|---|
CN110464720A (zh) | 2019-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109106760B (zh) | 肉苁蓉苯乙醇苷改善睡眠的新用途及其应用 | |
CN110742972B (zh) | 一种具有改善认知作用的中药组合物及其制备方法和中药制剂 | |
CN102014931A (zh) | 芍药甙的抗抑郁症用途、制备方法及其药物组合物 | |
CN1241574C (zh) | 一种解痉、镇痛药及制备方法 | |
CN102579554B (zh) | 花生茎叶提取物及其制备方法用途 | |
CN107951980B (zh) | 玉簪花及其提取物在制备治疗慢性前列腺炎的药物中的用途 | |
CN110464720B (zh) | 一种具有防治肠易激综合征的蝉蜕乙酰多巴胺多聚体组合物及其应用 | |
CN102274268B (zh) | 一种具有戒酒作用的中药活性提取物、其制备方法和应用 | |
CN116173177A (zh) | 一种持续改善男性性功能的药物组合物及制备方法 | |
CN103156923A (zh) | 啤酒花有效部位用于制备预防和改善抑郁症及其临床症状药物的应用 | |
KR20160094896A (ko) | 히드록시기 폴리메톡시플라본 화합물 및 그 유도체를 사용하는 방법 | |
US5378466A (en) | Therapeutic agent for allergic diseases | |
CN112843143A (zh) | 治疗便秘型肠易激综合征的中药组合物及其药剂和应用 | |
CN113368097A (zh) | 葛根素在制备预防和/或治疗肠易激综合征药物中的应用及药物 | |
EP3943095A1 (en) | Traditional chinese medicine laxative composition for treating constipation, preparation method therefor and application thereof | |
CN111035646A (zh) | 柠檬苦素在制备治疗预防自身免疫性睾丸炎药物中的应用 | |
CN110755486A (zh) | 一种治疗鼻渊的麻杏石甘汤加味中药组方 | |
CN109939175A (zh) | 润肠通便的中药组合物、其制备方法及应用 | |
CN114394931B (zh) | 具有血管舒张活性的单萜生物碱及其提取方法和应用 | |
CN105012382B (zh) | 核桃粕提取物及其制备方法和应用 | |
CN107375409B (zh) | 龙须藤多甲氧基总黄酮治疗和预防胃溃疡的应用 | |
CN115998798B (zh) | 一种用于治疗便秘的中药及其制备方法和应用 | |
CN109758506B (zh) | 具有改善睡眠功能的中药保健食品及其制备方法 | |
CN101698043A (zh) | 一种复方芦荟胶囊及其制备方法 | |
CN101766676A (zh) | 一种楹树提取物、其制备方法及其组合物与用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220225 Address after: 300410 2 East Road Puji River, Beichen District, Tianjin (Tsun Li modern Chinese medicine city) Applicant after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 210028, cross street, Hongshan Road, Jiangsu, Nanjing, 100 Applicant before: JIANGSU PROVINCE INSTITUTE OF TRADITIONAL CHINESE MEDICINE |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240502 Address after: 300410 2 East Road Puji River, Beichen District, Tianjin (Tsun Li modern Chinese medicine city) Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Country or region after: China Patentee after: Tianjin Tasly Modern TCM Resources Co.,Ltd. Address before: 300410 2 East Road Puji River, Beichen District, Tianjin (Tsun Li modern Chinese medicine city) Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Country or region before: China |